Novonix (NVX) Total Liabilities (2020 - 2025)

Novonix (NVX) has reported Total Liabilities for 6 consecutive years, with $121.2 million the latest figure, recorded in Q4 2025.

• Quarterly Total Liabilities rose 37.0% year-over-year to $121.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $121.2 million (up 37.0% YoY) and the FY2025 annual result came in at $121.2 million, up 37.0% from the prior year.
• Total Liabilities slipped to $121.2 million in Q4 2025 per NVX's latest filing, from $182.8 million in the prior quarter.
• Over the last five years, Total Liabilities for NVX reached as high as $182.8 million in Q2 2025 and fell as low as $13.0 million in Q2 2021.
• A 5-year average of $79.7 million and a median of $79.2 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities jumped 307.43% — and 2024, when it gained 4.85%.
• Year by year, Total Liabilities stood at $45.8 million in 2021, then advanced by 12.21% to $51.4 million in 2022, then soared by 54.58% to $79.4 million in 2023, then gained by 11.46% to $88.5 million in 2024, then soared by 37.0% to $121.2 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $121.2 million, $182.8 million, and $88.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.